Timing of drotrecogin alfa (activated) initiation in treatment of severe sepsis: a database cohort study of hospital mortality, length of stay, and costs

Author： Ernst F. R.   Johnston J. A.   Pulgar S.   He J.   Ball D. E.   Young J. K.   Cooper L. M.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.1, 2007-01, pp. : 235-244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

International integrated database for the evaluation of severe sepsis (INDEPTH): clinical evaluation committee report on the safety of drotrecogin alfa (activated) therapy

By Dhainaut Jean-François    

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1187-1197

Informa Healthcare

Access to resources Recommend Favorite

International INtegrated Database for the Evaluation of severe sePsis and drotrecogin alfa (activated) THerapy: component trials and statistical methods for INDEPTH

By Sashegyi Andreas   Trzaskoma Benjamin L.   Nelson David R.   Williams Mark D.   Macias William  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 1001-1012

Informa Healthcare

Access to resources Recommend Favorite

Evaluating the use of Drotrecogin alfa (activated) in adult severe sepsis: a Canadian multicenter observational study

By Kanji Salmaan   Perreault Marc   Chant Clarence   Williamson David   Burry Lisa  

Intensive Care Medicine, Vol. 33, Iss. 3, 2007-03 ,pp. : 517-523

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of mechanisms after post-hoc analyses of the drotrecogin alfa (activated) and antithrombin III trials in severe sepsis

By Wiedermann Christian   Kaneider Nicole  

Annals of Medicine, Vol. 36, Iss. 3, 2004-05 ,pp. : 194-203

Informa Healthcare

Access to resources Recommend Favorite

Time-course of neopterin levels in patients suffering from severe sepsis treated with and without Drotrecogin-alpha (activated)

By Behnes Michael   Brueckmann Martina   Wiessner Mike   Kettenmann Eva   Liebetrau Claudia   Lang Siegfried   Putensen Christian   Borggrefe Martin   Hoffmann Ursula  

Scandinavian Journal of Infectious Diseases, Vol. 40, Iss. 6-7, 2008-01 ,pp. : 503-508

Informa Healthcare

Access to resources Recommend Favorite